Introduction

The DASH Diet: A Guide to Managing Hypertension Through Nutrition

Hypertension, defined as a blood pressure of 130/80 mm Hg or higher, is a major global public health problem affecting over 1 billion adults worldwide, with prevalence rates of 30% to 45%.[1] Hypertension is the leading modifiable risk factor for cardiovascular disease, stroke, chronic kidney disease, and early death, significantly increasing disability and healthcare expenses. In the United States, nearly half of adults have hypertension, often undiagnosed or inadequately treated. Racial, ethnic, and socioeconomic disparities in hypertension prevalence are well documented, and rates, especially in low- and middle-income regions, are increasing.[2] Despite the availability of effective lifestyle changes and low-cost medications, detection and treatment efforts remain suboptimal. Additionally, people with hypertension often have other conditions, eg, obesity and diabetes, which elevate the risk of poor health outcomes. 

The Dietary Approaches to Stop Hypertension (DASH) diet originated from a multicenter, randomized clinical trial conducted in the early 1990s to evaluate the effects of dietary patterns on blood pressure. The study diet emphasized consumption of fruits, vegetables, whole grains, lean proteins, and low-fat dairy while limiting sodium, added sugars, and saturated fats. Participants who followed the eating plan for 8 weeks experienced significantly greater reductions in blood pressure compared with those on a control diet. These findings were the first to demonstrate that the DASH diet is a practical, evidence-based strategy for the prevention and management of hypertension.[3]

The American College of Cardiology (ACC), the American Heart Association (AHA), the Academy of Family Physicians, the American Medical Association, and many other professional organizations recommend the DASH diet to prevent and manage hypertension in adults. The 2025 AHA/ACC guidelines support the DASH eating plan, which focuses on fruits, vegetables, and low-fat dairy products, for individuals with elevated blood pressure or hypertension. This recommendation is backed by clinical trial evidence showing average reductions in systolic blood pressure of 1 to 13 mm Hg and diastolic reductions of 1 to 10 mm Hg. The guidelines also stress that the DASH diet should be part of a comprehensive lifestyle approach that includes regular physical activity, weight management, sodium reduction, and avoiding excessive alcohol intake to improve blood pressure control and lower cardiovascular risk.[4] 

Function

Physiological Basis of the DASH Diet

The DASH diet offers a balanced intake of macronutrients and micronutrients to support cardiovascular and metabolic health. Complex carbohydrates from whole grains, low-glycemic fruits, green leafy vegetables, and legumes supply energy, fiber, and essential micronutrients. Healthy fats are included in moderation, focusing on sources of unsaturated fatty acids, eg, olive oil, canola oil, nuts, seeds, avocados, hemp seeds, flax seeds, and fatty fish. These fats help reduce inflammation, raise HDL cholesterol, and lower LDL cholesterol.

Protein intake emphasizes plant-based sources and lean animal products, with foods high in potassium, magnesium, and calcium—nutrients that help regulate blood pressure through various physiological mechanisms. Potassium, abundant in fruits and vegetables like bananas, oranges, and spinach, promotes sodium excretion and reduces vascular smooth muscle contraction. Magnesium, found in whole grains, leafy greens, nuts, and seeds, acts as a natural calcium channel blocker, promoting vasodilation and improving endothelial function. Calcium, present in dairy foods, fortified soy products, and green leafy vegetables, supports vascular reactivity and helps relax smooth muscles. Together, these effects help maintain normal vascular resistance and prevent endothelial dysfunction. Limiting dietary sodium further lowers blood pressure by reducing extracellular fluid volume and vascular resistance. Additionally, the DASH diet avoids processed and cured meats, which are linked to increased hypertension risk due to their high sodium content, nitrate preservatives, and negative effects on vascular health function.[5][6]

The current version of the DASH diet features 2 evidence-based sodium targets, both endorsed by the National Heart, Lung, and Blood Institute and incorporated into the 2025 AHA/ACC hypertension guidelines. The general DASH diet permits up to 2,300 mg of sodium daily, aligning with existing dietary guidelines for Americans and suitable for most adults. The lower-sodium plan, limiting sodium to 1,500 mg daily, is advised for people with hypertension, high blood pressure, or other cardiovascular risk factors. Clinical trials indicate that reducing sodium to 1,500 mg daily results in further decreases in systolic blood pressure (approximately 2–7 mm Hg) compared to 2,300 mg daily intake.[7] 

Core Principles of the DASH Diet

The following principles comprise the DASH diet:

• High intake of fruits and vegetables, providing potassium, magnesium, fiber, and antioxidants (4–5 servings of fruits and 4–5 servings of vegetables daily)
• Low-fat or nonfat dairy products, supplying calcium and protein (2–3 servings daily)
• Minimally processed whole grains, rich in fiber and nutrients to promote satiety (6–8 servings daily)
• Lean protein sources, eg, fish, poultry, eggs, legumes, seeds, and nuts, rather than red or processed meats (2–3 servings daily) [8]
• Avoidance of foods high in saturated fats, including full-fat dairy products, fatty meats, processed foods with partially hydrogenated oils, and tropical oils, replaced with 2 to 3 servings of unsaturated or monounsaturated fats daily
• Sodium intake of 1,500 mg to no more than 2,300 mg per day [4] 
• Minimal consumption of sweetened beverages and foods with added sugars (≤5 servings per week)
• Balanced caloric intake to support weight management and overall health
• Moderate alcohol consumption, if included
• Focus on overall dietary patterns rather than individual nutrients [8] 

Issues of Concern

Implementation Barriers

Common barriers to adopting the DASH diet include cost, meal preparation time, limited access to healthy foods, lack of nutrition education, cultural preferences, and difficulty reducing sodium intake. Many patients find that consuming the recommended amounts of fruits, vegetables, nuts, and low-fat dairy can be expensive, especially for those in food deserts or with limited financial resources who may struggle to find or afford these foods.[9] Furthermore, reaching the DASH diet’s sodium goals can be difficult for those accustomed to high-salt diets or who rely heavily on processed or restaurant meals, as these are the main sources of dietary sodium rather than salt added during cooking or at the table. In the PREMIER trial, only 28% of participants reached the sodium goal of less than 1,500 mg/day at 6 months, although the less than 2,300 mg/day target was more achievable by reducing processed foods consumption.[4][9][10] 

Clinicians may encounter additional challenges, eg, limited time to counsel patients and insufficient training. Patients frequently report difficulty sticking to the diet because of unfamiliar serving sizes, limited cooking skills, or a lack of household support. Referring patients to a registered dietitian is advised for personalized guidance, although access might be limited. Some individuals view the DASH diet as incompatible with their traditional eating habits, but may be more open to culturally adapted or modified versions.

Misconceptions about the DASH diet include the belief that this plan is simply a low-salt eating protocol, that it requires costly or specialty foods, or that this diet is only meant for patients with hypertension. In reality, the DASH diet's effectiveness results from a synergistic combination of increased consumption of fruits, vegetables, whole grains, low-fat dairy, and nuts, along with reduced intake of saturated fats, red meat, and sweets. Focusing solely on sodium reduction or a single nutrient (eg, potassium or calcium) ignores the comprehensive nature of the dietary pattern and its overall cardiovascular benefits.[3][10] 

Another common implementation barrier is the misconception that the DASH diet is expensive or difficult to follow; however, this dietary plan is based on widely available foods, and individuals can substitute seasonal produce with frozen or canned low-sodium options.[10] Although processed "DASH-labeled" foods are marketed to meet DASH nutrient targets—typically lower in sodium, added sugars, and saturated fat—patients should remember that the core diet emphasizes whole, minimally processed foods to maximize nutritional value and cardiovascular benefits. Some clinicians and patients might confuse the DASH diet with the Mediterranean diet, as both promote plant-based foods, nuts, legumes, and whole grains. However, the DASH diet is specifically designed to lower blood pressure and emphasizes low-fat dairy, lean protein, and limited sodium. In contrast, the Mediterranean diet more broadly focuses on cardiovascular and metabolic health, with higher total fat intake from olive oil and fish, optional moderate wine consumption, and less strict nutrient limits.

The overlap in recommended foods and shared cardioprotective outcomes can cause confusion, highlighting the importance of clarifying each diet's unique goals and uses. Addressing these misconceptions during clinical visits can improve patient understanding, boost adherence, and help clinicians tailor dietary advice more effectively to individual cardiovascular risk profiles.

Clinical Significance

Evidence from landmark trials, including the DASH and DASH-Sodium studies, shows significant reductions in systolic and diastolic blood pressure within weeks of following the DASH diet, regardless of weight loss.[7] Improvements have also been observed in lipid profiles, insulin sensitivity, and overall cardiovascular risk. Adopting a diet rich in plant-based foods, whole grains, low-fat dairy products, and moderate sodium intake has proven effective in preventing and managing hypertension, especially among older adults. This is particularly true in studies with structured meal plans or frequent dietary guidance counseling.[11] 

Comparative research shows that the DASH diet rivals the Mediterranean diet in lowering cardiometabolic risk and provides explicit guidance on sodium intake and recommended food servings, which may make it easier for patients to follow.[10] Both diets have a plant-forward foundation, but DASH's specific emphasis on low-fat dairy and sodium restriction makes it especially suitable for primary and secondary prevention of hypertension and related cardiovascular events.[4] 

Since its introduction, the DASH diet has been extensively studied in patients with various chronic conditions. Clinical trials and observational studies demonstrate improvements in blood glucose control, triglycerides, LDL cholesterol, and insulin resistance, supporting its role as an effective adjunct to pharmacologic therapy in metabolic syndrome and type 2 diabetes.[10][12][13] The diet's emphasis on reducing sodium and increasing intake of potassium, magnesium, and calcium also benefits patients with heart failure and chronic kidney disease, where careful mineral balance is essential.[9][12] The American Diabetes Association endorses the DASH diet because it aligns with its recommendations to reduce saturated and trans fats, cholesterol, and added sugars while promoting fiber and whole grains.[9][10] 

Emerging evidence further supports potential benefits in metabolic dysfunction–associated steatotic liver disease, stroke prevention, and reduction of inflammatory and oxidative stress markers, reflecting its broad impact on metabolic and vascular health.[13][14][15] In addition, adherence to DASH has been associated with a lower incidence of colorectal cancer, diverticular disease, celiac disease, and all-cause mortality.[1][7][11][16] Prospective studies also link the diet to lower rates of heart failure incidence, hospitalization, and death in both men and women.[9][12]

Collectively, these findings underscore the clinical versatility of the DASH diet as a practical, evidence-based nutrition strategy for managing hypertension and multiple comorbid conditions. Its clear structure, specified number of servings per food group, and balanced composition make it one of the easiest dietary interventions to prescribe and monitor to improve patient outcomes through lifestyle modification.

Enhancing Healthcare Team Outcomes

Effective implementation of the DASH diet benefits from a team-based approach that leverages the expertise of physicians, advanced practice clinicians, nurses, dietitians, pharmacists, and social workers. Each interprofessional team member plays a distinct but complementary role in promoting adherence, patient education, and long-term lifestyle change. Physicians and advanced practitioners assess cardiovascular and metabolic risk, prescribe the DASH diet, and coordinate follow-up care. Dietitians provide individualized nutrition counseling, practical meal planning, and guidance on culturally adaptable substitutions. Nurses educate families and caregivers, monitor adherence, and reinforce lifestyle counseling during routine encounters. Pharmacists review medication interactions, provide education about the sodium content of foods in relation to antihypertensive therapy, and help patients interpret supplement or processed food labeling. Social workers address socioeconomic barriers, access to healthy foods, and community resources to support sustained dietary adherence.

Consistent interprofessional communication and coordination ensure that patients receive unified messaging, avoiding contradictory recommendations, and feel supported in making dietary changes. Utilizing structured tools, such as patient education materials, food logs, and digital health platforms, can enhance team-based care, increase patient engagement, and enable objective monitoring of adherence and outcomes. Ethical considerations, including respect for cultural preferences, shared decision-making, and equitable access to nutrition resources, are essential components of team-based strategies. By working together, the healthcare team can optimize patient-centered care, enhance cardiovascular and metabolic outcomes, and improve overall team performance and patient safety.

Review Questions

• Access free multiple choice questions on this topic.
• Comment on this article.

References

1.

Soltani S, Arablou T, Jayedi A, Salehi-Abargouei A. Adherence to the dietary approaches to stop hypertension (DASH) diet in relation to all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective cohort studies. Nutr J. 2020 Apr 22;19(1):37. [PMC free article: PMC7178992] [PubMed: 32321528]

2.

Levitan EB, Wolk A, Mittleman MA. Relation of consistency with the dietary approaches to stop hypertension diet and incidence of heart failure in men aged 45 to 79 years. Am J Cardiol. 2009 Nov 15;104(10):1416-20. [PMC free article: PMC2774905] [PubMed: 19892061]

3.

Yannakoulia M, Scarmeas N. Diets. N Engl J Med. 2024 Jun 13;390(22):2098-2106. [PubMed: 38865662]

4.

Jones DW, Ferdinand KC, Taler SJ, Johnson HM, Shimbo D, Abdalla M, Altieri MM, Bansal N, Bello NA, Bress AP, Carter J, Cohen JB, Collins KJ, Commodore-Mensah Y, Davis LL, Egan B, Khan SS, Lloyd-Jones DM, Melnyk BM, Mistry EA, Ogunniyi MO, Schott SL, Smith SC, Talbot AW, Vongpatanasin W, Watson KE, Whelton PK, Williamson JD., Peer Review Committee Members. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2025 Nov 04;86(18):1567-1678. [PubMed: 40815242]

5.

Urrico P. Nonpharmacological Interventions in the Management of Hypertension in the Adult Population With Type 2 Diabetes Mellitus. Can J Diabetes. 2018 Apr;42(2):196-198. [PubMed: 29602407]

6.

Garcia-Rios A, Ordovas JM, Lopez-Miranda J, Perez-Martinez P. New diet trials and cardiovascular risk. Curr Opin Cardiol. 2018 Jul;33(4):423-428. [PubMed: 29697543]

7.

Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, Simons-Morton DG, Karanja N, Lin PH., DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001 Jan 04;344(1):3-10. [PubMed: 11136953]

8.

Lin PH, Aickin M, Champagne C, Craddick S, Sacks FM, McCarron P, Most-Windhauser MM, Rukenbrod F, Haworth L., Dash-Sodium Collaborative Research Group. Food group sources of nutrients in the dietary patterns of the DASH-Sodium trial. J Am Diet Assoc. 2003 Apr;103(4):488-96. [PubMed: 12669013]

9.

Pilla SJ, Yeh HC, Mitchell CM, Miller ER, Oh S, White K, Durkin N, Stein AA, Charleston JB, Lu M, Hu X, Wu B, Selvin E, Fang M, Maruthur NM, Juraschek SP, Mueller NT, Wang NY, Appel LJ., DASH4D Collaborative Research Group. Dietary Patterns, Sodium Reduction, and Blood Pressure in Type 2 Diabetes: The DASH4D Randomized Clinical Trial. JAMA Intern Med. 2025 Aug 01;185(8):937-946. [PMC free article: PMC12150227] [PubMed: 40489102]

10.

Gardner CD, Vadiveloo MK, Petersen KS, Anderson CAM, Springfield S, Van Horn L, Khera A, Lamendola C, Mayo SM, Joseph JJ., American Heart Association Council on Lifestyle and Cardiometabolic Health. Popular Dietary Patterns: Alignment With American Heart Association 2021 Dietary Guidance: A Scientific Statement From the American Heart Association. Circulation. 2023 May 30;147(22):1715-1730. [PubMed: 37128940]

11.

Ozemek C, Laddu DR, Arena R, Lavie CJ. The role of diet for prevention and management of hypertension. Curr Opin Cardiol. 2018 Jul;33(4):388-393. [PubMed: 29771736]

12.

Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, Deswal A, Eckhardt LL, Goldberger ZD, Gopinathannair R, Gorenek B, Hess PL, Hlatky M, Hogan G, Ibeh C, Indik JH, Kido K, Kusumoto F, Link MS, Linta KT, Marcus GM, McCarthy PM, Patel N, Patton KK, Perez MV, Piccini JP, Russo AM, Sanders P, Streur MM, Thomas KL, Times S, Tisdale JE, Valente AM, Van Wagoner DR., Peer Review Committee Members. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024 Jan 02;149(1):e1-e156. [PMC free article: PMC11095842] [PubMed: 38033089]

13.

Valenzuela-Fuenzalida JJ, Bravo VS, Valarezo LM, Delgado Retamal MF, Leiva JM, Bruna-Mejías A, Nova-Baeza P, Orellana-Donoso M, Suazo-Santibañez A, Oyanedel-Amaro G, Gutierrez-Espinoza H. Effectiveness of DASH Diet versus Other Diet Modalities in Patients with Metabolic Syndrome: A Systematic Review and Meta-Analysis. Nutrients. 2024 Sep 10;16(18) [PMC free article: PMC11434995] [PubMed: 39339654]

14.

Sangouni AA, Hosseinzadeh M, Parastouei K. The effect of dietary approaches to stop hypertension (DASH) diet on fatty liver and cardiovascular risk factors in subjects with metabolic syndrome: a randomized controlled trial. BMC Endocr Disord. 2024 Jul 25;24(1):126. [PMC free article: PMC11270781] [PubMed: 39054440]

15.

Zare Z, Hosseinzadeh M, Sharuni F, Rohani FS, Hojjat H, Rahimpour S, Madadizadeh F, Zavar Reza J, Wong A, Nadjarzadeh A. The effect of the dietary approaches to stop hypertension diet on total antioxidant capacity, superoxide dismutase, catalase, and body composition in patients with non-alcoholic fatty liver disease: a randomized controlled trial. Front Nutr. 2023;10:1163516. [PMC free article: PMC10624175] [PubMed: 37927493]

16.

Tyson CC, Nwankwo C, Lin PH, Svetkey LP. The Dietary Approaches to Stop Hypertension (DASH) eating pattern in special populations. Curr Hypertens Rep. 2012 Oct;14(5):388-96. [PMC free article: PMC4377837] [PubMed: 22846984]

Disclosure: Sharon Daley declares no relevant financial relationships with ineligible companies.

Disclosure: Elsa Vadakekut declares no relevant financial relationships with ineligible companies.